Christi Shaw
CIK 1702473 · Executive Chairperson · last filed 2026-06-05
Christi Shaw is an Executive Chairperson who has filed 23 SEC Form 4 insider transactions across 5 companies since 2017. The most recent filing, for BEAM, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$3.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.44M
5
23
-$3.48M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BEAM | Director | — | $29.03 | — | $0 | 4 | 2026-06-05 |
| KYTX | Executive Chairperson | 66,741 | $8.05 | $537.6K | $0 | 5 | 2026-05-29 |
| AVTR | Director | 36,271 | $9.39 | $340.6K | $0 | 1 | 2023-05-15 |
| Avantor, Inc. (AVTRpA) Delisted | Director | 26,463 | $90.81 | $2.40M | -$381.2K | 6 | 2022-05-16 |
| LLY | SVP and Pres., Lilly Bio-Meds | 500 | $1133.00 | $566.5K | -$3.10M | 7 | 2019-05-16 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | BEAM | Grant (A) | — | $0 | EDGAR |
| 2026-05-29 | KYTX | Tax (F) | −4,194 | -$36.0K | EDGAR |
| 2026-01-14 | KYTX | Grant (A) | +54,301 | $0 | EDGAR |
| 2025-06-06 | BEAM | Grant (A) | — | $0 | EDGAR |
| 2025-06-02 | KYTX | Grant (A) | +16,634 | $0 | EDGAR |
| 2025-02-19 | KYTX | Grant (A) | — | $0 | EDGAR |
| 2024-09-18 | KYTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | BEAM | Grant (A) | — | $0 | EDGAR |
| 2023-12-14 | BEAM | Grant (A) | — | $0 | EDGAR |
| 2023-05-15 | AVTR | Grant (A) | +9,808 | $0 | EDGAR |